Odonate Therapeutics™

📍 San Diego, United States🗓 Founded 2013👥 122 employees
Pharmaceuticals🌐 odonate.com
Website LinkedIn
Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent belonging to a class of drugs known as taxanes, which are widely used in the treatment of cancer. In December 2017, Odonate initiated CONTESSA, a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with locally advanced or metastatic breast cancer. Odonate’s goal for tesetaxel is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Odonate Therapeutics™ founded?
Odonate Therapeutics™ was founded in 2013.
What industry is Odonate Therapeutics™ in?
Odonate Therapeutics™ operates in Pharmaceuticals. Find similar Pharmaceuticals investors on gritt.io.
Where is Odonate Therapeutics™ based?
Odonate Therapeutics™ is headquartered in San Diego, United States.